Marko Velimirovic
Marko Velimirovic publishes mostly in Cancer Research, Pulmonary and Respiratory Medicine and Oncology, on topics such as Cancer Genomics and Diagnostics, Advanced Breast Cancer Therapies and Cancer Cells and Metastasis.
- World rank
- #2,060,217 of 7,710,434 ranked researchers
- Rank in United States
- #623,302 of 1,627,098
- Works
- 95
- Citations
- 240
- Citations per work
- 2.5
What does Marko Velimirovic research?
Marko Velimirovic's work is mostly in Medicine (46%), Biochemistry, Genetics and Molecular Biology (35%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences4446.2%
- Medicine4446.2%
- Life Sciences3335.1%
- Everything else1818.7%
- 1Cancer Research27% of their works
- 2Pulmonary and Respiratory Medicine22% of their works
- 3Oncology21% of their works
- 4Genetics4% of their works
- 5Pathology and Forensic Medicine4% of their works
- 6Molecular Biology4% of their works
Research topics
Which keywords describe Marko Velimirovic's research?
The keywords of their largest research topics: Targeted Therapy, Cancer Genomics, Mutational Signatures, Breast Cancer, CDK4/6 Inhibitors, Palbociclib, Immunohistochemistry and Molecular Profiling.
- HER2
- Lung Tumors
- Gene Expression
- Breast Tumours
- ALK Inhibitors
- Cancer Stem Cells
- Molecular Profiling
- Palbociclib
- Breast Cancer
- Cancer Genomics
- Targeted Therapy
- Mutational Signatures
- CDK4/6 Inhibitors
- Immunohistochemistry
- Prognostic Markers
- Tumor Metastasis
- EGFR Mutations
- Cancer of Unknown Primary
- Metastasis
- Metastatic Carcinomas
- Trastuzumab
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 21 words, with their numbers
- Targeted Therapy372 topics
- Cancer Genomics301 topic
- Mutational Signatures301 topic
- Breast Cancer243 topics
- CDK4/6 Inhibitors151 topic
- Palbociclib151 topic
- Immunohistochemistry112 topics
- Molecular Profiling112 topics
- Prognostic Markers112 topics
- Cancer Stem Cells101 topic
- Tumor Metastasis101 topic
- ALK Inhibitors71 topic
- EGFR Mutations71 topic
- Breast Tumours61 topic
- Cancer of Unknown Primary61 topic
- Gene Expression61 topic
- Metastasis61 topic
- Lung Tumors51 topic
- Metastatic Carcinomas51 topic
- HER241 topic
- Trastuzumab41 topic
Where does Marko Velimirovic work?
Marko Velimirovic's main affiliation in the publication record is Massachusetts General Hospital, United States.
How many publications and citations does Marko Velimirovic have?
OpenAlex counts 95 works and 240 citations for Marko Velimirovic, an h-index of 9, ranking #2,060,217 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Marko Velimirovic. Posts are plain text and can be reported.